1234217-58-3

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-(2-bromopyridin-4-yl)acetate is used as a key intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique structure and reactivity allow for the creation of new drugs with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical sector, methyl 2-(2-bromopyridin-4-yl)acetate is utilized as a building block for the development of novel agrochemicals, such as pesticides and herbicides, for [application reason]. Its chemical properties contribute to the design of effective and targeted agrochemical products.
Used in Organic Synthesis:
Methyl 2-(2-bromopyridin-4-yl)acetate is employed as a versatile reactant in organic synthesis for [application reason]. Its ability to undergo multiple types of chemical reactions makes it a valuable component in the creation of a broad spectrum of organic compounds for various applications.
Used in Research and Development:
In the realm of research and development, methyl 2-(2-bromopyridin-4-yl)acetate is used as a crucial component in the exploration of new chemical reactions and the discovery of innovative compounds for [application reason]. Its presence in the lab accelerates the process of creating new molecules with potential applications in various industries.

Upstream product

• 4926-28-7 2-Bromo-4-picoline 
• 79-22-1 methyl chloroformate 
• 183483-29-6 2-(2-bromopyridin-4-yl)acetic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

Relevant academic research and scientific papers

Pyridineacetamide derivative serving as CDK inhibitor, and preparation method and application thereof

The invention belongs to the technical field of pyridineacetamide derivatives, and particularly relates to a pyridineacetamide derivative serving as a CDK inhibitor and a preparation method and application of the pyridine acetamide derivative. The pyridineacetamide derivative shows excellent CDK9/CDK7 enzyme inhibitory activity, and can be used for preparing drugs used for treating cancers, especially hematologic cancers including acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia, follicular lymphoma and the like and solid tumors such as breast cancer, prostate cancer, ovarian cancer, hepatocellular carcinoma, pancreatic cancer, kidney cancer, stomach cancer, colorectal cancer, lung cancer and the like.

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

A compound of Formula I or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate (" cGMP") and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula I or a pharmaceutically acceptable salt thereof.

BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS

The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.